维罗纳制药(VRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VRNA 维罗纳制药

停牌 10-06 16:00:00 EDT

106.91

+0.00

0.00%

最高106.91	最低106.91	成交量0.00
今开106.91	昨收106.91	日振幅0.00%
总市值91.93亿	流通市值67.20亿	总股本8,599万
成交额2.00亿	换手率0.00%	流通股本6,285万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VRNA","market":"US","secType":"STK","nameCN":"维罗纳制药","latestPrice":106.91,"timestamp":1759780800000,"preClose":106.91,"halted":3,"volume":0,"delay":0,"floatShares":62852600,"shares":85991299,"eps":-1.025739,"marketStatus":"停牌","change":0,"latestTime":"10-06 16:00:00 EDT","open":106.91,"high":106.91,"low":106.91,"amount":200070103.338764,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.025739,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":1,"adrRate":8,"listingDate":1493265600000,"exchange":"NASDAQ","adjPreClose":106.91,"volumeRatio":0},"requestUrl":"/m/hq/s/VRNA/tweets","defaultTab":"tweets","newsList":[{"id":"2573516869","title":"默克完成对维罗纳制药的收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2573516869","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573516869?lang=zh_cn&edition=full","pubTime":"2025-10-07 18:51","pubTimestamp":1759834291,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0320765489.SGD","LU1989771016.USD","SG9999001176.SGD","SG9999015341.SGD","IE000M9KFDE8.USD","BK4559","LU1989772840.SGD","LU0265550359.USD","LU1066051498.USD","IE00BFTCPJ56.SGD","LU0238689110.USD","LU1093756325.SGD","LU2106854487.HKD","LU2361044865.SGD","LU0208291251.USD","LU0203345920.USD","BK4007","LU2468319806.SGD","LU0861579265.USD","IE00B2B36J28.USD","IE00BN8TJ469.HKD","LU0965509101.SGD","LU1571399168.USD","MRK","LU0106261372.USD","LU1934455863.HKD","LU0289739699.SGD","LU0203347892.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","IE00BSNM7G36.USD","LU1035773651.USD","LU1934455277.USD","LU1917777945.USD","LU1116320901.HKD","LU1934455194.USD","SG9999015358.SGD","LU1983299246.USD","LU2361045086.USD","LU0070302665.USD","LU1066051811.HKD","LU2112291526.USD","SG9999014567.USD","LU0965508806.USD","IE00B1BXHZ80.USD","VRNA","LU1989772923.USD","LU1061106388.HKD","BK4550"],"gpt_icon":0},{"id":"2557530524","title":"维罗纳制药8月6日成交额为1.96亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557530524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557530524?lang=zh_cn&edition=full","pubTime":"2025-08-07 15:58","pubTimestamp":1754553480,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，维罗纳制药成交额为1.96亿美元，成交额较昨日增加116.44%，当日成交量为186.55万股。维罗纳制药于2025年8月6日跌0.01%，报105.39美元，该股过去5个交易日涨0.24%，年初至今涨126.94%，过去60日涨66.44%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-06|1.96亿|116.44%|186.55万|#|2025-08-05|9072.11万|-42.08%|86.14万|#|2025-08-04|1.57亿|-52.74%|148.78万|#|2025-08-01|3.31亿|43.83%|315.15万|#|2025-07-31|2.30亿|-1.24%|219.13万|Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807163857a6d859c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807163857a6d859c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2557555321","title":"维罗纳制药8月5日成交额为9072.11万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557555321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557555321?lang=zh_cn&edition=full","pubTime":"2025-08-06 15:48","pubTimestamp":1754466526,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，维罗纳制药成交额为9072.11万美元，成交额较昨日减少42.08%，当日成交量为86.14万股。维罗纳制药于2025年8月5日跌0.07%，报105.4美元，该股过去5个交易日涨0.22%，年初至今涨126.96%，过去60日涨59.07%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-05|9072.11万|-42.08%|86.14万|#|2025-08-04|1.57亿|-52.74%|148.78万|#|2025-08-01|3.31亿|43.83%|315.15万|#|2025-07-31|2.30亿|-1.24%|219.13万|#|2025-07-30|2.33亿|12.59%|221.73万|Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806161511a6d61e66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806161511a6d61e66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2557366996","title":"维罗纳制药8月4日成交额为1.57亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557366996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557366996?lang=zh_cn&edition=full","pubTime":"2025-08-05 15:45","pubTimestamp":1754379943,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，维罗纳制药成交额为1.57亿美元，成交额较昨日减少52.74%，当日成交量为148.78万股。维罗纳制药于2025年8月4日涨0.28%，报105.47美元，该股过去5个交易日涨0.36%，年初至今涨127.11%，过去60日涨52.55%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-04|1.57亿|-52.74%|148.78万|#|2025-08-01|3.31亿|43.83%|315.15万|#|2025-07-31|2.30亿|-1.24%|219.13万|#|2025-07-30|2.33亿|12.59%|221.73万|#|2025-07-29|2.07亿|-53.18%|196.93万|Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805160228a6d405d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805160228a6d405d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2556934448","title":"维罗纳制药7月31日成交额为2.30亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556934448","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556934448?lang=zh_cn&edition=full","pubTime":"2025-08-01 16:09","pubTimestamp":1754035773,"startTime":"0","endTime":"0","summary":"美东时间2025年7月31日，维罗纳制药成交额为2.30亿美元，成交额较昨日减少1.24%，当日成交量为219.13万股。维罗纳制药于2025年7月31日跌0.05%，报105.09美元，该股过去5个交易日涨0.09%，年初至今涨126.29%，过去60日涨45.45%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-31|2.30亿|-1.24%|219.13万|#|2025-07-30|2.33亿|12.59%|221.73万|#|2025-07-29|2.07亿|-53.18%|196.93万|#|2025-07-28|4.43亿|140.93%|420.79万|#|2025-07-25|1.84亿|-33.72%|174.64万|Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801163807a46f5536&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801163807a46f5536&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2555014878","title":"维罗纳制药7月29日成交额为2.07亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555014878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555014878?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:18","pubTimestamp":1753863503,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，维罗纳制药成交额为2.07亿美元，成交额较昨日减少53.18%，当日成交量为196.93万股。维罗纳制药于2025年7月29日涨0.08%，报105.17美元，该股过去5个交易日涨0.15%，年初至今涨126.46%，过去60日涨45.54%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-29|2.07亿|-53.18%|196.93万|#|2025-07-28|4.43亿|140.93%|420.79万|#|2025-07-25|1.84亿|-33.72%|174.64万|#|2025-07-24|2.77亿|-31.18%|264.09万|#|2025-07-23|4.03亿|15.17%|383.76万|Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730170752a6c96a16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730170752a6c96a16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2555360280","title":"维罗纳制药7月28日成交额为4.43亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555360280","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555360280?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:12","pubTimestamp":1753776735,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日，维罗纳制药成交额为4.43亿美元，成交额较昨日增加140.93%，当日成交量为420.79万股。维罗纳制药于2025年7月28日跌0.2%，报105.09美元，该股过去5个交易日涨0.18%，年初至今涨126.29%，过去60日涨45.82%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-28|4.43亿|140.93%|420.79万|#|2025-07-25|1.84亿|-33.72%|174.64万|#|2025-07-24|2.77亿|-31.18%|264.09万|#|2025-07-23|4.03亿|15.17%|383.76万|#|2025-07-22|3.50亿|22.26%|333.29万|Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729164623a4694cd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729164623a4694cd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2554034715","title":"维罗纳制药7月25日成交额为1.84亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554034715","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554034715?lang=zh_cn&edition=full","pubTime":"2025-07-26 15:56","pubTimestamp":1753516577,"startTime":"0","endTime":"0","summary":"美东时间2025年7月25日，维罗纳制药成交额为1.84亿美元，成交额较昨日减少33.72%，当日成交量为174.64万股。维罗纳制药于2025年7月25日涨0.29%，报105.3美元，该股过去5个交易日涨0.38%，年初至今涨126.74%，过去60日涨43.81%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-25|1.84亿|-33.72%|174.64万|#|2025-07-24|2.77亿|-31.18%|264.09万|#|2025-07-23|4.03亿|15.17%|383.76万|#|2025-07-22|3.50亿|22.26%|333.29万|#|2025-07-21|2.86亿|-8.01%|272.64万|Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726155626a6c2c86c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726155626a6c2c86c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2554520357","title":"维罗纳制药7月24日成交额为2.77亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554520357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554520357?lang=zh_cn&edition=full","pubTime":"2025-07-25 15:42","pubTimestamp":1753429351,"startTime":"0","endTime":"0","summary":"美东时间2025年7月24日，维罗纳制药成交额为2.77亿美元，成交额较昨日减少31.18%，当日成交量为264.09万股。维罗纳制药于2025年7月24日涨0.05%，报105.0美元，该股过去5个交易日涨0.21%，年初至今涨126.1%，过去60日涨52.55%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-24|2.77亿|-31.18%|264.09万|#|2025-07-23|4.03亿|15.17%|383.76万|#|2025-07-22|3.50亿|22.26%|333.29万|#|2025-07-21|2.86亿|-8.01%|272.64万|#|2025-07-18|3.11亿|-39.25%|296.40万|Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725155556a462d89c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725155556a462d89c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2553277426","title":"维罗纳制药7月23日成交额为4.03亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553277426","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553277426?lang=zh_cn&edition=full","pubTime":"2025-07-24 15:32","pubTimestamp":1753342333,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日，维罗纳制药成交额为4.03亿美元，成交额较昨日增加15.17%，当日成交量为383.76万股。维罗纳制药于2025年7月23日跌0.06%，报104.95美元，该股过去5个交易日涨0.2%，年初至今涨125.99%，过去60日涨60.33%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-23|4.03亿|15.17%|383.76万|#|2025-07-22|3.50亿|22.26%|333.29万|#|2025-07-21|2.86亿|-8.01%|272.64万|#|2025-07-18|3.11亿|-39.25%|296.40万|#|2025-07-17|5.12亿|-29.64%|488.55万|Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724154154a6bf240a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724154154a6bf240a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2553290139","title":"维罗纳制药7月22日成交额为3.50亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553290139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553290139?lang=zh_cn&edition=full","pubTime":"2025-07-23 15:31","pubTimestamp":1753255865,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日，维罗纳制药成交额为3.50亿美元，成交额较昨日增加22.26%，当日成交量为333.29万股。维罗纳制药于2025年7月22日涨0.1%，报105.01美元，该股过去5个交易日涨0.23%，年初至今涨126.12%，过去60日涨62.1%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-22|3.50亿|22.26%|333.29万|#|2025-07-21|2.86亿|-8.01%|272.64万|#|2025-07-18|3.11亿|-39.25%|296.40万|#|2025-07-17|5.12亿|-29.64%|488.55万|#|2025-07-16|7.27亿|-34.12%|694.16万|Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723153958a6bcb63f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723153958a6bcb63f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2553928717","title":"维罗纳制药7月21日成交额为2.86亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553928717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553928717?lang=zh_cn&edition=full","pubTime":"2025-07-22 15:16","pubTimestamp":1753168591,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日，维罗纳制药成交额为2.86亿美元，成交额较昨日减少8.01%，当日成交量为272.64万股。维罗纳制药于2025年7月21日涨0.0%，报104.9美元，该股过去5个交易日涨0.22%，年初至今涨125.88%，过去60日涨65.69%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-21|2.86亿|-8.01%|272.64万|#|2025-07-18|3.11亿|-39.25%|296.40万|#|2025-07-17|5.12亿|-29.64%|488.55万|#|2025-07-16|7.27亿|-34.12%|694.16万|#|2025-07-15|11.04亿|-32.54%|1054.06万|Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722151640a45b97b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722151640a45b97b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2552441967","title":"维罗纳制药7月18日成交额为3.11亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552441967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552441967?lang=zh_cn&edition=full","pubTime":"2025-07-19 14:52","pubTimestamp":1752907928,"startTime":"0","endTime":"0","summary":"美东时间2025年7月18日，维罗纳制药成交额为3.11亿美元，成交额较昨日减少39.25%，当日成交量为296.40万股。维罗纳制药于2025年7月18日涨0.11%，报104.9美元，该股过去5个交易日涨0.07%，年初至今涨125.88%，过去60日涨69.17%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-18|3.11亿|-39.25%|296.40万|#|2025-07-17|5.12亿|-29.64%|488.55万|#|2025-07-16|7.27亿|-34.12%|694.16万|#|2025-07-15|11.04亿|-32.54%|1054.06万|#|2025-07-14|16.37亿|42.99%|1562.42万|Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719145215a454eb9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719145215a454eb9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2552101553","title":"维罗纳制药7月16日成交额为7.27亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552101553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552101553?lang=zh_cn&edition=full","pubTime":"2025-07-17 15:30","pubTimestamp":1752737435,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日，维罗纳制药成交额为7.27亿美元，成交额较昨日减少34.12%，当日成交量为694.16万股。维罗纳制药于2025年7月16日跌0.03%，报104.74美元，该股过去5个交易日跌0.03%，年初至今涨125.54%，过去60日涨77.77%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-16|7.27亿|-34.12%|694.16万|#|2025-07-15|11.04亿|-32.54%|1054.06万|#|2025-07-14|16.37亿|42.99%|1562.42万|#|2025-07-11|11.45亿|-31.72%|1091.87万|#|2025-07-10|16.77亿|-75.63%|1598.91万|Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717154022a45075a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717154022a45075a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2550426666","title":"默克公司拟100亿美元收购维罗纳制药，斩获COPD明星药","url":"https://stock-news.laohu8.com/highlight/detail?id=2550426666","media":"药事纵横","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550426666?lang=zh_cn&edition=full","pubTime":"2025-07-10 06:02","pubTimestamp":1752098575,"startTime":"0","endTime":"0","summary":"7月9日，默克公司宣布将以每股美国存托股票107美元的价格，总计约100亿美元收购维罗纳制药。通过此次交易，默克将获得维罗纳制药旗下治疗慢性阻塞性肺病的药物Ohtuvayre。Ohtuvayre获批用于成人慢性阻塞性肺疾病的维持治疗。温瑞维尔是一种激活素信号抑制剂，默克公司于2021年以115亿美元收购Acceleron制药公司时将其收入囊中。此次交易已获双方董事会一致批准，预计将于第四季度完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710060531a6a01914&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710060531a6a01914&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0203345920.USD","LU0266013472.USD","LU0320765489.SGD","LU1917777945.USD","LU0211331839.USD","BK4550","SG9999001440.SGD","LU1291159041.SGD","LU1989772840.SGD","IE0009355771.USD","LU2023250504.SGD","IE00BSNM7G36.USD","LU2361044949.HKD","SG9999013999.USD","LU2361045086.USD","SG9999014567.USD","SG9999001176.SGD","LU0106261372.USD","LU0098860793.USD","VRNA","LU1066051498.USD","IE00BJJMRZ35.SGD","LU1037948541.HKD","BK4007","BK4533","LU0122379950.USD","LU0265550946.USD","LU0070302665.USD","LU0238689110.USD","LU2023250843.SGD","SG9999002232.USD","LU1093756168.USD","LU1069347547.HKD","LU0965509283.SGD","LU1116320901.HKD","LU1934455863.HKD","IE00BFTCPJ56.SGD","IE00BBT3K403.USD","LU0289739699.SGD","LU0058720904.USD","IE000M9KFDE8.USD","LU0208291251.USD","LU1057294990.SGD","SGXZ57979304.SGD","LU0965509010.AUD","LU1989772923.USD","LU1116320737.USD","SG9999015341.SGD","MRK","LU2324357040.USD"],"gpt_icon":0},{"id":"2550639900","title":"维罗纳制药美股盘前涨超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550639900","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550639900?lang=zh_cn&edition=full","pubTime":"2025-07-09 18:46","pubTimestamp":1752057995,"startTime":"0","endTime":"0","summary":"维罗纳制药美股盘前涨超20%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507093452310378.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"1129222845","title":"默沙东同意以107美元/ADS的价格收购维罗纳制药，总交易价值约100亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1129222845","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129222845?lang=zh_cn&edition=full","pubTime":"2025-07-09 18:38","pubTimestamp":1752057507,"startTime":"0","endTime":"0","summary":"7月9日，$默沙东(MRK)$和专注于呼吸系统疾病的生物制药公司$维罗纳制药(VRNA)$公司今天宣布，两家公司已达成最终协议，根据该协议，默沙东将通过其子公司以每股美国存托股票 (ADS)107美元的价格收购维罗纳制药，每股美国存托股票代表8股维罗纳制药普通股，总交易价值约为100亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c625593cee617ed4779e9d7f535c3364","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"默沙东同意以107美元/ADS的价格收购维罗纳制药，总交易价值约100亿美元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU0265550359.USD","IE00BJT1NW94.SGD","LU0965508806.USD","LU1057294990.SGD","LU1571399168.USD","LU1066051498.USD","LU0965509283.SGD","LU0289739699.SGD","IE00BLSP4239.USD","BK4588","LU0006306889.USD","VRNA","BK4559","MRK","LU1093756325.SGD","LU1037948897.HKD","LU1037948541.HKD","LU1066053197.SGD","BK4550"],"gpt_icon":0},{"id":"1192625853","title":"维罗纳制药短线拉升涨超18%，默沙东接近达成以100亿美元的价格将其收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1192625853","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192625853?lang=zh_cn&edition=full","pubTime":"2025-07-09 13:26","pubTimestamp":1752038807,"startTime":"0","endTime":"0","summary":"7月9日（周三），维罗纳制药短线拉升涨超18%，默沙东接近达成以100亿美元的价格将其收购。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c625593cee617ed4779e9d7f535c3364","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRNA"],"gpt_icon":0},{"id":"1154297258","title":"默沙东据报接近以约100亿美元收购维罗纳制药","url":"https://stock-news.laohu8.com/highlight/detail?id=1154297258","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154297258?lang=zh_cn&edition=full","pubTime":"2025-07-09 13:25","pubTimestamp":1752038719,"startTime":"0","endTime":"0","summary":"据英国《金融时报》周三报道， $默沙东(MRK)$ (Merck,)正接近达成一项价值约100亿美元的交易，收购专注于肺部疾病的生物技术公司 $维罗纳制药(VRNA)$ （Verona Pharma）。报道援引三位知情人士消息称，默沙东将为Verona的每股美国存托股份(ADS)支付107美元。受消息影响，维罗纳制药夜盘升18%。","market":"hk","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c625593cee617ed4779e9d7f535c3364","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"默沙东据报接近以约100亿美元收购维罗纳制药","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","VRNA"],"gpt_icon":0},{"id":"2550871502","title":"【维罗纳制药美股夜盘短线拉升超16%】呼吸系统药物制造商维罗纳制药美股夜盘短线拉升超16%，报道称默沙东接近达成以100亿美元的价格将其收购。","url":"https://stock-news.laohu8.com/highlight/detail?id=2550871502","media":"金融界","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550871502?lang=zh_cn&edition=full","pubTime":"2025-07-09 13:10","pubTimestamp":1752037830,"startTime":"0","endTime":"0","summary":"呼吸系统药物制造商维罗纳制药美股夜盘短线拉升超16%，报道称默沙东接近达成以100亿美元的价格将其收购。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c625593cee617ed4779e9d7f535c3364","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/09131051580478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0985320562.USD","LU0058720904.USD","LU0006306889.USD","BK4533","LU0965509283.SGD","LU2361045086.USD","SG9999001440.SGD","MRK","LU1037948541.HKD","LU1291159041.SGD","VRNA","LU0265550946.USD","LU0234572021.USD","BK4516","LU1066053197.SGD","LU0106261372.USD","IE00BJJMRZ35.SGD","LU1934455863.HKD","LU1934455194.USD","LU1066051498.USD","LU1699723380.USD","SG9999014559.SGD","LU2361044865.SGD","LU0211331839.USD","LU0265550359.USD","IE00BN8TJ469.HKD","LU0289739699.SGD","LU2023250504.SGD","LU2089984988.USD","IE00BJT1NW94.SGD","SG9999001176.SGD","SG9999001176.USD","LU1430594728.SGD","SGXZ57979304.SGD","LU1162221912.USD","LU1093756168.USD","LU1585245621.USD","SG9999002224.SGD","LU1983299246.USD","LU1057294990.SGD","LU1116320737.USD","IE00B4R5TH58.HKD","LU1989772840.SGD","LU0208291251.USD","LU0238689110.USD","BK4588","SG9999002232.USD","LU1917777945.USD","LU1989771016.USD","LU1941712348.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.veronapharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.0045},{"period":"6month","weight":0.1595},{"period":"1year","weight":1.7231},{"period":"ytd","weight":1.3021}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"维罗纳制药公司根据英格兰及威尔士的法律以Isis Resources plc为名于2005年2月24日注册成立。2006年9月，该公司收购了在加拿大注册成立的私人公司Rhinopharma Limited，并更名为维罗纳制药公司。该公司是一家临床阶段的生物制药公司，专注于开发和商业化创新治疗方法，用于治疗具有显著未满足的医疗需求的呼吸系统疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.042371},{"month":2,"riseRate":0.5,"avgChangeRate":0.048229},{"month":3,"riseRate":0.25,"avgChangeRate":-0.023426},{"month":4,"riseRate":0.375,"avgChangeRate":-0.038912},{"month":5,"riseRate":0.555556,"avgChangeRate":-0.009341},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.015219},{"month":7,"riseRate":0.666667,"avgChangeRate":0.137147},{"month":8,"riseRate":0.555556,"avgChangeRate":0.106058},{"month":9,"riseRate":0.444444,"avgChangeRate":0.007366},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.008021},{"month":11,"riseRate":0.375,"avgChangeRate":0.006476},{"month":12,"riseRate":0.75,"avgChangeRate":0.295436}],"exchange":"NASDAQ","name":"维罗纳制药","nameEN":"Verona Pharma plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"维罗纳制药(VRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供维罗纳制药(VRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"维罗纳制药,VRNA,维罗纳制药股票,维罗纳制药股票老虎,维罗纳制药股票老虎国际,维罗纳制药行情,维罗纳制药股票行情,维罗纳制药股价,维罗纳制药股市,维罗纳制药股票价格,维罗纳制药股票交易,维罗纳制药股票购买,维罗纳制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"维罗纳制药(VRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供维罗纳制药(VRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}